TGI
JNCE
TRV GP III’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-1,148,780
| Closed | -$2.69M | – | 6 |
|
2022
Q3 | $2.69M | Hold |
1,148,780
| – | – | 1.17% | 6 |
|
2022
Q2 | $3.48M | Hold |
1,148,780
| – | – | 1.42% | 7 |
|
2022
Q1 | $7.8M | Hold |
1,148,780
| – | – | 2.12% | 7 |
|
2021
Q4 | $9.59M | Sell |
1,148,780
-1,900,000
| -62% | -$15.9M | 2.4% | 7 |
|
2021
Q3 | $22.7M | Hold |
3,048,780
| – | – | 4.3% | 6 |
|
2021
Q2 | $20.7M | Hold |
3,048,780
| – | – | 3.62% | 7 |
|
2021
Q1 | $31.3M | Hold |
3,048,780
| – | – | 3.96% | 6 |
|
2020
Q4 | $21.3M | Hold |
3,048,780
| – | – | 1.83% | 7 |
|
2020
Q3 | $24.9M | Hold |
3,048,780
| – | – | 2.09% | 7 |
|
2020
Q2 | $21M | Hold |
3,048,780
| – | – | 3.07% | 5 |
|
2020
Q1 | $14.5M | Hold |
3,048,780
| – | – | 3.94% | 5 |
|
2019
Q4 | $26.6M | Hold |
3,048,780
| – | – | 11.75% | 3 |
|
2019
Q3 | $10.2M | Hold |
3,048,780
| – | – | 5.75% | 4 |
|
2019
Q2 | $15.1M | Hold |
3,048,780
| – | – | 6.42% | 3 |
|
2019
Q1 | $18.9M | Hold |
3,048,780
| – | – | 9.26% | 3 |
|
2018
Q4 | $10.3M | Hold |
3,048,780
| – | – | 8.61% | 3 |
|
2018
Q3 | $19.8M | Hold |
3,048,780
| – | – | 8.85% | 3 |
|
2018
Q2 | $23.4M | Hold |
3,048,780
| – | – | 7.78% | 3 |
|
2018
Q1 | $68.1M | Hold |
3,048,780
| – | – | 24.53% | 2 |
|
2017
Q4 | $38.9M | Buy |
+3,048,780
| New | +$38.9M | 13.61% | 3 |
|